MMP9 and stage 5 chronic kidney disease: Because the extent of fibrosis is strongly associated with the rate of progression to end stage renal disease in ADPKD patients [45], this result could account for the protective role of MMP9 in the pathology, as demonstrated by improved kidney function and life expectancy.